Saturday, October 25, 2014 Last update: 2:03 PM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

The Best of U.S. Company Tech News - Updated Daily

Wednesday, August 3, 2011

  • Posted at 1:05 PM
    AUSTIN, TX -- (Marketwire) -- 08/03/11 -- SolarWinds® (NYSE: SWI), a leading provider of powerful and affordable IT management software, today reported results for its second quarter ended June 30, 2011. Record quarterly total revenue of $45.8 million, representing 29% year-over-year growth. GAAP operating income of $19.1 million and non-GAAP operating income of $23.3 million, or a non-GAAP operating margin of 51%. GAAP diluted earnings per share of $0.18 and non-GAAP diluted earnings per share of $0.22. Cash flows ... read more
  • Posted at 1:05 PM
    SAN JOSE, CA -- (Marketwire) -- 08/03/11 -- Quantum Corp. (NYSE: QTM), the leading global specialist in backup, recovery and archive, today announced that Standard & Poor's Rating Services has upgraded its outlook on the company from stable to positive based on the company's ongoing debt reduction and prospects for sustained lower leverage levels. Standard & Poor's has also affirmed its "B" corporate credit rating on Quantum. "This upgrade speaks to the ongoing improvement in Quantum's balance sheet, as ... read more
  • Posted at 1:05 PM
    PORT HUENEME, CA -- (Marketwire) -- 08/03/11 -- Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce they have entered into an agreement for marketing and sales with SAFC®, a business unit of Sigma-Aldrich (NASDAQ: SIAL) a global leader in biopharmaceutical contract manufacturing. Under the agreement, Stellar will produce KLH commercial intermediate and SAFC will sell, distribute and market cGMP-grade HMW KLH (high molecular weight keyhole limpet hemocyanin) that uses only Stellar aquaculture-derived KLH for ... read more
  • Posted at 1:05 PM
    SanDisk Corporation (NASDAQ:SNDK), a global leader in flash memory storage solutions, today announced that Sanjay Mehrotra, President and Chief Executive Officer, will address the investment community attending the Oppenheimer 14th Annual Technology and Communications Conference on Wednesday, August 10, 2011 at 9:35 am, Eastern Time. The ... read more
  • Posted at 1:03 PM
    The Susan G. Komen for the Cure® Los Angeles County Affiliate, part of the world's largest breast cancer advocacy organization, is proud to announce a partnership with Grammy Award nominated recording artist and long-time breast cancer awareness advocate, Kelly Price. Susan G. Komen for the Cure® is the world's leader in breast cancer research, awareness, and education. The Los Angeles County Affiliate has raised more than $8.9 to fund breast cancer programs and research in the last 15 years, ... read more
  • Posted at 1:02 PM
    Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today revenues for the second quarter of 2011 were $111.2 million, a 17 percent increase over revenues of $95.1 million in the second quarter of 2010. Results for all periods of fiscal 2010 exclude contributions from the company's International Technidyne Corporation (ITC) Division. Thoratec completed the divestiture of ITC in November of 2010. For the quarter ended July 2, 2011, Thoratec ... read more
  • Posted at 1:02 PM
    Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that it has acquired the medical business of Levitronix LLC ("Levitronix Medical") for an upfront cash payment of $110 million, as well as potential future cash earnout payments of up to $40 million. This transaction solidifies Thoratec's position as the leading, full-line provider of mechanical circulatory support products for both acute and chronic needs, advancing the company's ... read more
  • Posted at 1:02 PM
    MakeMusic, Inc. (NASDAQ:MMUS) today announced monthly subscription results for SmartMusic®, the interactive music software for band, orchestra and voice. SmartMusic subscriptions as of July month-end numbered 177,868, representing an increase of 4,573 from the previous month and a 24% increase over the ... read more
  • Posted at 1:01 PM
    MakeMusic, Inc. (NASDAQ:MMUS) announced financial results for the three months and six months ended June 30, 2011. “While our results this quarter were impacted by the delay of the annual release of our notation product Finale®, we continued to gain ... read more
  • Posted at 1:01 PM
  • Posted at 1:01 PM
    Analog Devices, Inc. (NYSE: ADI) today announced it will release financial results for the third quarter of fiscal 2011, ended July 30, 2011, after the market closes on Tuesday, August 16, 2011. Following the issuance of the press release regarding ... read more
  • Posted at 1:01 PM
    Insight Enterprises, Inc. (Nasdaq: NSIT) (the “Company”) today reported results of operations for the quarter ended June 30, 2011. Second Quarter Highlights For the second quarter of 2011 compared to the second quarter of 2010: ... read more
  • Posted at 1:01 PM
    MOUNTAIN VIEW, CA -- (Marketwire) -- 08/03/11 -- Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in flexible catheter robotics and the developer of robotic technology for accurate 3D control of catheter movement, today reported business highlights and financial results for the second quarter and six months ended June 30, 2011. The Company continues to build its commercial momentum as it posted its second consecutive strong quarter of system sales in its electrophysiology (EP) business, strengthened its EP sales ... read more
  • Posted at 1:01 PM
    MEMC Electronic Materials, Inc. (NYSE: WFR) and its solar energy subsidiary, SunEdison, today announced a definitive agreement to acquire privately-held Fotowatio Renewable Ventures, Inc. ("FRV U.S."), the 100% owned U.S. subsidiary of Fotowatio Renewable Ventures ("FRV"), a leading global developer, operator and owner of solar power plants. At closing, MEMC will pay $112 million, plus repayment of approximately $22.9 million in intercompany loans and capital contributions. The final purchase price is subject to adjustment based on the actual ... read more
  • Posted at 1:01 PM
    Dendreon Corporation (Nasdaq: DNDN) today reported results for the second quarter ended June 30, 2011. Net revenue for the quarter ended June 30, 2011 was $49.6 million compared to $2.8 million for the quarter ended June 30, 2010. This included a $1.9 million reserve for estimated rebates and chargebacks associated with either Medicaid patients or other pricing discounts offered pursuant to mandatory federal and state government programs. Gross revenue for the quarter ended June 30, 2011, excluding ... read more
  • Posted at 1:01 PM
    ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today reported financial results for the three-month period and fiscal year ended June 30, 2011. ... read more
  • Posted at 1:01 PM
    Valence Technology, Inc. (NASDAQ: VLNC), a leading U.S.-based developer and manufacturer of advanced energy storage solutions today reported financial results for its fiscal 2012 first quarter ended June 30, 2011. Highlights - Fiscal 2012 First Quarter compared to Fiscal ... read more
  • Posted at 1:00 PM
    Systemax Inc. (NYSE: SYX) today announced financial results for the second quarter and six months ended June 30, 2011. Performance Summary ... read more
  • Posted at 1:00 PM
    Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported financial results for the three and six months ended June 30, 2011. Cadence commercially launched OFIRMEV® (acetaminophen) injection, the first and only intravenous formulation of acetaminophen to be approved in the U.S., in January 2011. As of July 31, 2011, OFIRMEV had received formulary acceptance at over 1,150 hospitals, representing more than 50% of the ... read more
  • Posted at 1:00 PM
    Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June 30, 2011. Total revenue increased to $50.8 million in the second quarter of 2011, compared with $43.4 million in the second quarter of 2010. Product revenue was $50.5 million in the second quarter of 2011, an increase of 19 percent, compared with $42.5 million in the second quarter of 2010. Net income was $2.3 million in the second quarter of 2011, compared with net ... read more